PH-064 is primarily utilized in the field of medicinal chemistry and pharmacology due to its potential therapeutic properties. It has been studied for its role as a selective antagonist, particularly in targeting specific receptors in the central nervous system. This makes it a promising candidate for research into neurological disorders, such as anxiety, depression, and schizophrenia, where modulating receptor activity can help alleviate symptoms. Additionally, PH-064 is investigated for its potential in pain management, as it may interfere with pain signaling pathways. Its application extends to preclinical studies, where it serves as a tool compound to better understand receptor mechanisms and develop novel treatments for various conditions.